News

Mason engineers and partners receive $3M award to build new technology for personalized musculoskeletal injury rehabilitation to support troop readiness

Musculoskeletal injury (MSKI) is the most common form of medical injury experienced by Service members. Clinical interventions for MSKIs lack objective measures to determine their effectiveness, putting affected military personnel at risk of further damage if they return to duty  before fully recovering.

George Mason University bioengineer Dr. Parag Chitnis, an associate professor in the Department of Bioengineering and a member of the Institute for Biohealth Innovation (IBI), and his team are developing quantitative assessments that can both prevent and monitor MSKIs in Service members.

In partnership with Cephasonics Ultrasound, an ultrasound systems and technology company in California, and Infinite Biomedical Technologies, a biotechnology company in Maryland, the team has been selected by the United States Army Medical Research and Development Command to receive nearly $3M from the United States Department of Defense, awarded through the Medical Technology Enterprise Consortium (MTEC). The award will support the team’s development of wearable, compact, and hands-free ultrasound systems to assess rehabilitation and recovery from MSKIs through measurements of muscle structure and function during physical activity, with a specific focus on knee injuries.

“MTEC aims to facilitate prototype advancement in support of the Warfighters’ MSKI needs, “ said Dr. Lauren Palestrini, MTEC’s chief science officer. “We are excited to issue this award to the team at George Mason University and believe it has the potential to make great strides in military health and ultrasound research.”

Prior to this award, Dr. Chitnis and Dr. Siddhartha Sikdar, a professor in the Department of Bioengineering and a member of the IBI, formed the Training and Recovery Augmented with Ultrasound Myography and Assessment (TRAUMA) program. With funding from the Department of Defense’s Military Operational Medicine Research Program, TRAUMA’s goal is to develop ultrasound systems that can be used to evaluate MSKIs in dynamic settings. The award from MTEC enables the team to further advance their ongoing research.

“The ability to objectively monitor both injury and the recovery process is key to the continued health of our Service men and women,” said Dr. Elizabeth Russell Esposito, the program area manager for Musculoskeletal Injury Treatment and Rehabilitation at the Military Operational Medicine Research Program. “The solutions that Dr. Chitnis and his team are developing will augment the existing capabilities of our clinical teams to support medical readiness.”

While ultrasound is the diagnostic standard for MSKIs, diagnostic criteria are based on subjective interpretation of images and greatly rely on an operator’s level of expertise and amount of training received. Additionally, bulky ultrasound probes are ill-suited for the continuous monitoring of muscles during physical movement. For example, their size frequently prevents probes from maintaining adequate skin contact and their position on the body while a patient is performing rehabilitation exercises. Dr. Chitnis and his team aim to address these limitations with their revolutionary approach.

The team plans to use wearable, miniaturized ultrasound sensors that can be adhered to the body like a bandage, making the technology hands-free. The sensors can connect to a smartphone or tablet and will work in tandem with two systems: motion mode and brightness mode. Motion mode imaging provides a one-dimensional view of an object, while brightness mode imaging produces a two-dimensional display. Through former research, Dr. Chitnis, Dr. Sikdar, and their teams have already created a motion-mode system. The brightness mode system will be fabricated with the help of Cephasonics Ultrasound.

“Cephasonics Ultrasound is thrilled to have the opportunity to contribute our ultrasound technology to help address the pressing needs of not only our military, but also of the broader rehabilitation field,” said Randall Whiting, chief operating officer of Cephasonics Ultrasound.

The project will be broken up into three parts. First, the team will interview civilian and active-duty military clinicians, as well as athletic trainers, to better understand the gaps in care for MSKIs and how their ultrasound systems can aid in filling them. Next, they will develop and refine the motion-mode and brightness-mode systems in order to optimize image quality, along with performing benchtop validation testing to ensure that the systems serve the needs of the user. Finally, the team will test their wearable ultrasound systems for selected clinical use cases.

The third step incorporates assistance from Dr. Margaret Jones, a professor in the School of Sport, Recreation, and Tourism Management and a member of the IBI. Dr. Jones, who specializes in sports medicine, physiotherapy, and MSKIs, is also the director of the Patriot Performance Lab. She will support the team in recruiting Mason athletes and carrying out preliminary testing.

Other Mason collaborators include Dr. Pilgyu Kang, an assistant professor in the Department of Mechanical Engineering and a member of the IBI, and Dr. Qi Wei, an associate professor in the Department of Bioengineering and a member of the IBI.

Amy Adams, executive director of the IBI, is proud of the multidisciplinary efforts taking place at Mason.

“By harnessing the extraordinary power of working across disciplines, our researchers are able to address complex health challenges through a unique lens,” said Adams. “Collaborations among our diverse research community are fundamental to delivering impactful scientific innovations.”

Dr. Chitnis remarked that he hopes the smaller ultrasound systems eventually can be deployed in remote locations, during routine physical training for military personnel, and in ambulances. Ultimately he would like to see the ultrasound technology expand for use in a range of medical ailments and emergencies in both civilian and military settings.

“I am constantly amazed with this team’s innovative spirit and their drive to make radical improvements in ultrasound sensing and imaging,” said Dr. Chitnis. “It’s an ambitious endeavor, but knowing the people involved, I am confident that we will see through our mission.”

The views expressed in this news release/article are those of the authors and may not reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government.

Recent News

02/09/2026

Activation Capital Expands Frontier BioHealth and Strengthens its Continuum of Support for Life Sciences Founders

Activation Capital today announced enhancements to Frontier BioHealth, building on the program’s successful 2024 launch and inaugural cohort while reinforcing its broader continuum of life sciences entrepreneurship programs designed to help science-driven companies progress toward commercialization and investor readiness. Frontier BioHealth was created to address a critical gap facing emerging biohealth founders: access to practical

02/04/2026

Governor Spanberger Announces Expansion of Paid Internship Opportunities with Virginia Businesses

Governor Abigail Spanberger today launched InternshipsVA, a new statewide program to help Virginia employers design and launch high-quality, paid internships for higher education students in Virginia. The Commonwealth has committed $14.5 million each year to support this program. The Governor was joined by leaders of the Virginia Chamber of Commerce, the Virginia Economic Development Partnership

02/03/2026

SSI Diagnostica Group Acquires InDevR

SSI Diagnostica Group, a global company specializing in testing solutions for infectious diseases, has announced the acquisition of InDevR, a Colorado-based provider of advanced multiplexed solutions for vaccine testing and quality control. The addition strengthens SSID Group’s leadership in pneumococcal vaccine QC testing with next-generation multiplexing assays and enhanced customization capabilities. InDevR will advance the Group’s offering by